Neuroscientific Biopharmaceuticals Ltd Total Liabilities

Latest as of December 2025: AU$207.87K AUD ≈ $147.08K USD

Neuroscientific Biopharmaceuticals Ltd total liabilities. Based on the latest financial reports, Neuroscientific Biopharmaceuticals Ltd (NSB) has total liabilities worth AU$207.87K AUD (≈ $147.08K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check NSB asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Neuroscientific Biopharmaceuticals Ltd (2016–2025)

Total liabilities of Neuroscientific Biopharmaceuticals Ltd from 2016 to 2025. This chart illustrates how Neuroscientific Biopharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data.

Neuroscientific Biopharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Neuroscientific Biopharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Yong Tai Bhd KLSE:7066	Malaysia	RM433.15 Million
Seker Finansal Kiralama AS IS:SEKFK	Turkey	TL5.11 Billion
Prizma Pres Matbaacilik Yayincilik Sanayi ve Ticaret AS IS:PRZMA	Turkey	TL7.55 Million
Encorp Bhd KLSE:6076	Malaysia	RM465.43 Million
Playtech Plc LSE:PTEC	UK	GBX765.50 Million
Digital Graphics Incorporation KQ:043360	Korea	₩12.51 Billion
Park Ha Biological Technology Co., Ltd. NASDAQ:BYAH	USA	$1.58 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Neuroscientific Biopharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Neuroscientific Biopharmaceuticals Ltd asset portfolio.

Liquidity & Leverage Metrics

Neuroscientific Biopharmaceuticals Ltd Total Liabilities Ratios Explained

Neuroscientific Biopharmaceuticals Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	31.62	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	5.33	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.01	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.01	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neuroscientific Biopharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neuroscientific Biopharmaceuticals Ltd (2016–2025)

The table below shows the annual total liabilities of Neuroscientific Biopharmaceuticals Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$149.22K ≈ $105.59K	+74.16%
2024-06-30	AU$85.68K ≈ $60.63K	-85.66%
2023-06-30	AU$597.36K ≈ $422.67K	-73.06%
2022-06-30	AU$2.22 Million ≈ $1.57 Million	+892.65%
2021-06-30	AU$223.41K ≈ $158.08K	+152.35%
2020-06-30	AU$88.53K ≈ $62.64K	+41.70%
2019-06-30	AU$62.48K ≈ $44.21K	-18.21%
2018-06-30	AU$76.39K ≈ $54.05K	+77.02%
2017-06-30	AU$43.15K ≈ $30.53K	-64.66%
2016-06-30	AU$122.12K ≈ $86.41K	--

About Neuroscientific Biopharmaceuticals Ltd

AU:NSB Australia Biotechnology

Market Cap

$12.71 Million

AU$17.96 Million AUD

Market Cap Rank

#26298 Global

#1177 in Australia

Share Price

AU$0.05

Change (1 day)

+3.85%

52-Week Range

AU$0.05 - AU$0.17

All Time High

AU$0.52